Targeted immunotherapy for pediatric solid tumors

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

ABSTRACT: Metastatic and refractory pediatric solid tumor malignancies continue to have a poor outcome despite the > 80% cure rates appreciated in many pediatric cancers. Targeted immunotherapy is impacting treatment and survival in these aggressive tumors. We review current promising immunotherapeutic approaches in the pediatric oncology solid tumor setting.

Original languageEnglish (US)
JournalOncoImmunology
Volume5
Issue number3
DOIs
StatePublished - Mar 3 2016

Fingerprint

Immunotherapy
Pediatrics
Neoplasms
Therapeutics

Keywords

  • Immunotherapy
  • pediatric oncology
  • solid tumors

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

Targeted immunotherapy for pediatric solid tumors. / Kopp, Lisa M; Katsanis, Emmanuel.

In: OncoImmunology, Vol. 5, No. 3, 03.03.2016.

Research output: Contribution to journalArticle

@article{0eeefa60e6844f0189afc5129dda9d7b,
title = "Targeted immunotherapy for pediatric solid tumors",
abstract = "ABSTRACT: Metastatic and refractory pediatric solid tumor malignancies continue to have a poor outcome despite the > 80{\%} cure rates appreciated in many pediatric cancers. Targeted immunotherapy is impacting treatment and survival in these aggressive tumors. We review current promising immunotherapeutic approaches in the pediatric oncology solid tumor setting.",
keywords = "Immunotherapy, pediatric oncology, solid tumors",
author = "Kopp, {Lisa M} and Emmanuel Katsanis",
year = "2016",
month = "3",
day = "3",
doi = "10.1080/2162402X.2015.1087637",
language = "English (US)",
volume = "5",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Landes Bioscience",
number = "3",

}

TY - JOUR

T1 - Targeted immunotherapy for pediatric solid tumors

AU - Kopp, Lisa M

AU - Katsanis, Emmanuel

PY - 2016/3/3

Y1 - 2016/3/3

N2 - ABSTRACT: Metastatic and refractory pediatric solid tumor malignancies continue to have a poor outcome despite the > 80% cure rates appreciated in many pediatric cancers. Targeted immunotherapy is impacting treatment and survival in these aggressive tumors. We review current promising immunotherapeutic approaches in the pediatric oncology solid tumor setting.

AB - ABSTRACT: Metastatic and refractory pediatric solid tumor malignancies continue to have a poor outcome despite the > 80% cure rates appreciated in many pediatric cancers. Targeted immunotherapy is impacting treatment and survival in these aggressive tumors. We review current promising immunotherapeutic approaches in the pediatric oncology solid tumor setting.

KW - Immunotherapy

KW - pediatric oncology

KW - solid tumors

UR - http://www.scopus.com/inward/record.url?scp=84961576020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961576020&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2015.1087637

DO - 10.1080/2162402X.2015.1087637

M3 - Article

VL - 5

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 3

ER -